Overview
- RIKEN-led researchers report that smokers with ulcerative colitis carry mouth-associated Streptococcus in the colonic mucosa, a pattern not seen in ex-smokers.
- Metabolomic profiling linked smoking to elevated hydroquinone, which in mice promoted Streptococcus growth within the gut’s mucus layer.
- Administering Streptococcus mitis to mouse models reduced inflammation in ulcerative colitis but worsened it in Crohn's disease.
- Mechanistically, S. mitis induced Th1 responses that counter Th2-driven inflammation in ulcerative colitis yet exacerbate Th1-driven pathology in Crohn's disease.
- The authors propose exploring targeted microbes or hydroquinone-like metabolites as potential therapies, stressing that smoking remains unsafe and clinical testing is still needed.